nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—CYP2C19—urine—polycystic ovary syndrome	0.0391	0.133	CbGeAlD
Loratadine—CYP2C9—urine—polycystic ovary syndrome	0.0303	0.103	CbGeAlD
Loratadine—CYP3A4—urine—polycystic ovary syndrome	0.0231	0.0785	CbGeAlD
Loratadine—CYP2D6—urine—polycystic ovary syndrome	0.0227	0.0773	CbGeAlD
Loratadine—Lethargy—Metformin—polycystic ovary syndrome	0.00961	0.0549	CcSEcCtD
Loratadine—KCNH2—endometrium—polycystic ovary syndrome	0.00882	0.03	CbGeAlD
Loratadine—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.0086	0.0492	CcSEcCtD
Loratadine—KCNH2—uterus—polycystic ovary syndrome	0.00813	0.0276	CbGeAlD
Loratadine—CYP2C8—endometrium—polycystic ovary syndrome	0.00807	0.0274	CbGeAlD
Loratadine—KCNH2—pituitary gland—polycystic ovary syndrome	0.00798	0.0271	CbGeAlD
Loratadine—CYP2C8—pituitary gland—polycystic ovary syndrome	0.00731	0.0248	CbGeAlD
Loratadine—Drowsiness—Metformin—polycystic ovary syndrome	0.00726	0.0415	CcSEcCtD
Loratadine—KCNH2—adrenal gland—polycystic ovary syndrome	0.00713	0.0242	CbGeAlD
Loratadine—HRH1—endometrium—polycystic ovary syndrome	0.00707	0.024	CbGeAlD
Loratadine—CYP2C19—vagina—polycystic ovary syndrome	0.00693	0.0235	CbGeAlD
Loratadine—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00687	0.0392	CcSEcCtD
Loratadine—KCNH2—female gonad—polycystic ovary syndrome	0.00665	0.0226	CbGeAlD
Loratadine—KCNH2—vagina—polycystic ovary syndrome	0.00661	0.0225	CbGeAlD
Loratadine—CYP2C19—endocrine gland—polycystic ovary syndrome	0.00648	0.022	CbGeAlD
Loratadine—HRH1—adipose tissue—polycystic ovary syndrome	0.00637	0.0216	CbGeAlD
Loratadine—KCNH2—endocrine gland—polycystic ovary syndrome	0.00619	0.021	CbGeAlD
Loratadine—CYP2C8—vagina—polycystic ovary syndrome	0.00605	0.0205	CbGeAlD
Loratadine—Immune system disorder—Metformin—polycystic ovary syndrome	0.00589	0.0336	CcSEcCtD
Loratadine—HRH1—adrenal gland—polycystic ovary syndrome	0.00572	0.0194	CbGeAlD
Loratadine—CYP2C8—endocrine gland—polycystic ovary syndrome	0.00566	0.0192	CbGeAlD
Loratadine—Dysgeusia—Metformin—polycystic ovary syndrome	0.00556	0.0317	CcSEcCtD
Loratadine—HRH1—female gonad—polycystic ovary syndrome	0.00533	0.0181	CbGeAlD
Loratadine—HRH1—vagina—polycystic ovary syndrome	0.0053	0.018	CbGeAlD
Loratadine—ABCB1—embryo—polycystic ovary syndrome	0.00529	0.018	CbGeAlD
Loratadine—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00526	0.0301	CcSEcCtD
Loratadine—Malaise—Metformin—polycystic ovary syndrome	0.00512	0.0292	CcSEcCtD
Loratadine—Syncope—Metformin—polycystic ovary syndrome	0.00509	0.0291	CcSEcCtD
Loratadine—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00503	0.0171	CbGeAlD
Loratadine—Palpitations—Metformin—polycystic ovary syndrome	0.00501	0.0286	CcSEcCtD
Loratadine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00499	0.0285	CcSEcCtD
Loratadine—HRH1—endocrine gland—polycystic ovary syndrome	0.00496	0.0168	CbGeAlD
Loratadine—Hypertension—Metformin—polycystic ovary syndrome	0.0049	0.028	CcSEcCtD
Loratadine—Chest pain—Metformin—polycystic ovary syndrome	0.00483	0.0276	CcSEcCtD
Loratadine—Myalgia—Metformin—polycystic ovary syndrome	0.00483	0.0276	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.0048	0.0274	CcSEcCtD
Loratadine—Discomfort—Metformin—polycystic ovary syndrome	0.00477	0.0273	CcSEcCtD
Loratadine—Shock—Metformin—polycystic ovary syndrome	0.00456	0.026	CcSEcCtD
Loratadine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00454	0.0259	CcSEcCtD
Loratadine—Skin disorder—Metformin—polycystic ovary syndrome	0.0045	0.0257	CcSEcCtD
Loratadine—ABCB1—adrenal cortex—polycystic ovary syndrome	0.00433	0.0147	CbGeAlD
Loratadine—Hypotension—Metformin—polycystic ovary syndrome	0.00433	0.0247	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00422	0.0241	CcSEcCtD
Loratadine—Paraesthesia—Metformin—polycystic ovary syndrome	0.00416	0.0238	CcSEcCtD
Loratadine—Somnolence—Metformin—polycystic ovary syndrome	0.00412	0.0235	CcSEcCtD
Loratadine—Dyspepsia—Metformin—polycystic ovary syndrome	0.00408	0.0233	CcSEcCtD
Loratadine—CYP2D6—female gonad—polycystic ovary syndrome	0.00406	0.0138	CbGeAlD
Loratadine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.004	0.0228	CcSEcCtD
Loratadine—Fatigue—Metformin—polycystic ovary syndrome	0.00399	0.0228	CcSEcCtD
Loratadine—Constipation—Metformin—polycystic ovary syndrome	0.00396	0.0226	CcSEcCtD
Loratadine—ABCB1—endometrium—polycystic ovary syndrome	0.00387	0.0131	CbGeAlD
Loratadine—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00383	0.013	CbGeAlD
Loratadine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00382	0.0218	CcSEcCtD
Loratadine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00379	0.0216	CcSEcCtD
Loratadine—CYP2D6—endocrine gland—polycystic ovary syndrome	0.00377	0.0128	CbGeAlD
Loratadine—Abdominal pain—Metformin—polycystic ovary syndrome	0.00366	0.0209	CcSEcCtD
Loratadine—ABCB1—uterus—polycystic ovary syndrome	0.00357	0.0121	CbGeAlD
Loratadine—ABCB1—pituitary gland—polycystic ovary syndrome	0.0035	0.0119	CbGeAlD
Loratadine—ABCB1—adipose tissue—polycystic ovary syndrome	0.00349	0.0118	CbGeAlD
Loratadine—Asthenia—Metformin—polycystic ovary syndrome	0.00332	0.019	CcSEcCtD
Loratadine—Diarrhoea—Metformin—polycystic ovary syndrome	0.00317	0.0181	CcSEcCtD
Loratadine—ABCB1—adrenal gland—polycystic ovary syndrome	0.00313	0.0106	CbGeAlD
Loratadine—Dizziness—Metformin—polycystic ovary syndrome	0.00306	0.0175	CcSEcCtD
Loratadine—Vomiting—Metformin—polycystic ovary syndrome	0.00294	0.0168	CcSEcCtD
Loratadine—Rash—Metformin—polycystic ovary syndrome	0.00292	0.0167	CcSEcCtD
Loratadine—ABCB1—female gonad—polycystic ovary syndrome	0.00292	0.00991	CbGeAlD
Loratadine—Dermatitis—Metformin—polycystic ovary syndrome	0.00292	0.0167	CcSEcCtD
Loratadine—Headache—Metformin—polycystic ovary syndrome	0.0029	0.0166	CcSEcCtD
Loratadine—ABCB1—vagina—polycystic ovary syndrome	0.0029	0.00985	CbGeAlD
Loratadine—Nausea—Metformin—polycystic ovary syndrome	0.00275	0.0157	CcSEcCtD
Loratadine—ABCB1—endocrine gland—polycystic ovary syndrome	0.00271	0.00922	CbGeAlD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000308	0.000581	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000302	0.00057	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000299	0.000564	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000298	0.000561	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—AKR1C2—polycystic ovary syndrome	0.000294	0.000554	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—TEAD2—polycystic ovary syndrome	0.000294	0.000554	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000288	0.000542	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000287	0.000541	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	0.000287	0.000541	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000283	0.000533	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000282	0.000532	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000278	0.000525	CbGpPWpGaD
Loratadine—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000278	0.000524	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PNPLA2—polycystic ovary syndrome	0.000276	0.00052	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000275	0.000519	CbGpPWpGaD
Loratadine—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000274	0.000517	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000273	0.000514	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	0.00027	0.00051	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	0.00027	0.00051	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	0.000268	0.000505	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	0.000268	0.000505	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—SRD5A1—polycystic ovary syndrome	0.000262	0.000493	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.00026	0.00049	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000258	0.000486	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000257	0.000485	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000256	0.000482	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000254	0.000478	CbGpPWpGaD
Loratadine—HRH1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000252	0.000474	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.00025	0.000471	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—STAR—polycystic ovary syndrome	0.00025	0.00047	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000247	0.000465	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PNPLA2—polycystic ovary syndrome	0.000246	0.000464	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000245	0.000461	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000242	0.000456	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	0.00024	0.000453	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000238	0.000448	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000235	0.000443	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	0.000234	0.00044	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FST—polycystic ovary syndrome	0.000229	0.000432	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000228	0.00043	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000228	0.000429	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000227	0.000427	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000226	0.000427	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	0.000225	0.000423	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000224	0.000422	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000224	0.000422	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000224	0.000422	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	0.000223	0.00042	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	0.000222	0.000419	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.00022	0.000415	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000219	0.000412	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—STAR—polycystic ovary syndrome	0.000217	0.00041	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000217	0.00041	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000215	0.000405	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	0.000213	0.000401	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	0.000212	0.0004	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000212	0.000399	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000211	0.000398	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.00021	0.000395	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SCT—polycystic ovary syndrome	0.00021	0.000395	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000208	0.000392	CbGpPWpGaD
Loratadine—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000207	0.000391	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000207	0.00039	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	0.000205	0.000386	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	0.000203	0.000383	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000201	0.000378	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.0002	0.000377	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000199	0.000375	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	0.000199	0.000374	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000196	0.00037	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000195	0.000367	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000194	0.000366	CbGpPWpGaD
Loratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000194	0.000366	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	0.000194	0.000365	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	0.000194	0.000365	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000192	0.000362	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	0.000189	0.000357	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	0.000189	0.000357	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000187	0.000353	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000185	0.000349	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	0.000183	0.000345	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	0.000183	0.000344	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000182	0.000344	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000182	0.000343	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	0.000181	0.000341	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000179	0.000338	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000178	0.000335	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000177	0.000333	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000177	0.000333	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000174	0.000328	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	0.000173	0.000326	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	0.000173	0.000326	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000172	0.000323	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000171	0.000322	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	0.000169	0.000318	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—LHB—polycystic ovary syndrome	0.000169	0.000318	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	0.000169	0.000318	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000165	0.000311	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	0.000164	0.000308	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	0.000163	0.000308	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000163	0.000307	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000162	0.000305	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00016	0.000302	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	0.00016	0.000301	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	0.000159	0.000299	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000159	0.000299	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	0.000158	0.000297	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	0.000157	0.000297	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	0.000155	0.000293	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	0.000154	0.00029	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	0.000151	0.000285	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	0.00015	0.000284	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	0.00015	0.000283	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.00015	0.000283	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	0.000149	0.000281	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	0.000149	0.000281	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000148	0.000279	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000148	0.000279	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000148	0.000278	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000148	0.000278	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000147	0.000277	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	0.000146	0.000275	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	0.000142	0.000268	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000142	0.000268	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	0.000141	0.000266	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000141	0.000265	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	0.00014	0.000265	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.00014	0.000265	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	0.000139	0.000262	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	0.000138	0.000261	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000137	0.000259	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	0.000137	0.000259	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	0.000137	0.000258	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000137	0.000258	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	0.000135	0.000254	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000134	0.000253	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	0.000134	0.000253	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000134	0.000253	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	0.000133	0.000251	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	0.000133	0.00025	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000132	0.000249	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	0.000132	0.000248	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	0.00013	0.000245	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.00013	0.000245	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	0.000129	0.000244	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000129	0.000243	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000129	0.000243	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	0.000128	0.000241	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	0.000126	0.000237	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	0.000124	0.000234	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000124	0.000234	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	0.000124	0.000234	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	0.000123	0.000232	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000123	0.000232	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	0.000123	0.000231	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000122	0.000231	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000122	0.00023	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	0.000122	0.000229	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000121	0.000228	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000121	0.000227	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—TH—polycystic ovary syndrome	0.00012	0.000226	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.000119	0.000225	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	0.000117	0.00022	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	0.000116	0.000218	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	0.000115	0.000216	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	0.000114	0.000215	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	0.000114	0.000215	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000113	0.000214	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	0.000113	0.000213	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	0.00011	0.000207	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000108	0.000203	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—TH—polycystic ovary syndrome	0.000107	0.000202	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000106	0.0002	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—TH—polycystic ovary syndrome	0.000105	0.000197	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	0.000104	0.000197	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	0.000104	0.000196	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000102	0.000192	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	0.000102	0.000191	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—TH—polycystic ovary syndrome	9.86e-05	0.000186	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	9.83e-05	0.000185	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	9.81e-05	0.000185	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	9.81e-05	0.000185	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—TH—polycystic ovary syndrome	9.78e-05	0.000184	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	9.59e-05	0.000181	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	9.57e-05	0.00018	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	9.51e-05	0.000179	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	9.34e-05	0.000176	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IRS2—polycystic ovary syndrome	9.08e-05	0.000171	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	9.05e-05	0.000171	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	9.02e-05	0.00017	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	8.94e-05	0.000169	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—LEP—polycystic ovary syndrome	8.88e-05	0.000167	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	8.86e-05	0.000167	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	8.76e-05	0.000165	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	8.75e-05	0.000165	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	8.54e-05	0.000161	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	8.45e-05	0.000159	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	8.34e-05	0.000157	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	8.26e-05	0.000156	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	8.14e-05	0.000153	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	8.12e-05	0.000153	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	8.05e-05	0.000152	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	8.02e-05	0.000151	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	7.98e-05	0.00015	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IRS1—polycystic ovary syndrome	7.92e-05	0.000149	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	7.91e-05	0.000149	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	7.72e-05	0.000145	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	7.67e-05	0.000145	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—POMC—polycystic ovary syndrome	7.63e-05	0.000144	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	7.6e-05	0.000143	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—INS—polycystic ovary syndrome	7.59e-05	0.000143	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	7.57e-05	0.000143	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	7.45e-05	0.00014	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	7.37e-05	0.000139	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IGF1—polycystic ovary syndrome	7.34e-05	0.000138	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—AKT2—polycystic ovary syndrome	7.33e-05	0.000138	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	7.27e-05	0.000137	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	7.21e-05	0.000136	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	7.19e-05	0.000136	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.97e-05	0.000131	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	6.78e-05	0.000128	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	6.72e-05	0.000127	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	6.7e-05	0.000126	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	6.6e-05	0.000124	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—INS—polycystic ovary syndrome	6.57e-05	0.000124	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	6.45e-05	0.000122	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	6.27e-05	0.000118	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	5.98e-05	0.000113	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	5.9e-05	0.000111	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	5.89e-05	0.000111	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—INS—polycystic ovary syndrome	5.86e-05	0.00011	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	5.83e-05	0.00011	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—POMC—polycystic ovary syndrome	5.75e-05	0.000108	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—INS—polycystic ovary syndrome	5.72e-05	0.000108	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—IL6—polycystic ovary syndrome	5.61e-05	0.000106	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	5.5e-05	0.000104	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	5.45e-05	0.000103	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	5.42e-05	0.000102	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	5.39e-05	0.000102	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	5.37e-05	0.000101	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—INS—polycystic ovary syndrome	5.34e-05	0.000101	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	5.26e-05	9.92e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	5.01e-05	9.45e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.79e-05	9.04e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	4.75e-05	8.96e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	4.43e-05	8.35e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	3.59e-05	6.77e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	3.54e-05	6.68e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	3.52e-05	6.64e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IL6—polycystic ovary syndrome	3.32e-05	6.25e-05	CbGpPWpGaD
